biotech peptides retatrutide The trillion-dollar peptide. Appearing on @tbpn, Andrew Huberman said could be the peptide that “changes everything.” Now in Phase III clinical trials, it's shown up to 30% body weight loss in Retatrutide (RETA-10) 112mg Research Peptide

Injecting through clothing or into areas with poor hygiene increases infection risk

Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease

NHMRC: National Health and Medical Research Council

These drugs are FDA-approved for chronic weight management, alongside diet and exercise, in adults with obesity or overweight and at least one weight-related health condition (e.g., type 2 diabetes, high blood pressure)

They are very much operant or classical conditioning